Navigation Links
5 advocacy organizations win travel awards to attend World Conference on Lung Cancer in Amsterdam
Date:6/1/2011

Denver, Colorado (June 1, 2011) Five advocacy organizations from India, Australia and the United States have been granted travel awards by the International Association for the Study of Lung Cancer (IASLC) to send representatives to the 14th World Conference on Lung Cancer, July 3-7 in Amsterdam.

The winners are:

  • The Australian Lung Foundation (Australia): The Australian Lung Foundation is the premier organization for lung health in Australia, providing medical and support group representation nationwide. http://www.lungfoundation.com.au/

  • Jill's Legacy (USA): Jill's Legacy is an advisory board to the Bonnie J. Addario Lung Cancer Foundation, made up of young professionals who have been personally touched by lung cancer. http://www.lungcancerfoundation.org/

  • Health Alert Organization of India (India): HAOI deals directly with patients' issues including supportive care, treatment economics, social obstacles and cultural barriers in lung cancer care.

  • Lung Cancer Foundation of America (USA): LCFA is a nonprofit organization dedicated to providing the necessary and critical funding for creative and leading-edge lung cancer research programs. http://www.lcfamerica.org/

  • Uniting Against Lung Cancer (USA): Uniting Against Lung Cancer funds innovative lung cancer research to find a cure for the nation's leading cancer killer. It also works to increase awareness of the disease, including in people who have never smoked. http://www.unitingagainstlungcancer.org/

The awards, which cover one representative from each organization, include free registration, five nights' accommodation and a fixed amount to cover travel expenses to the World Conference on Lung Cancer, the world's largest meeting dedicated to lung cancer and thoracic malignancies. Recipients also will enjoy free IASLC affiliate membership for one year.

"All funds raised by Jill's Legacy are going directly to young researchers, so we must be as informed as possible on lung cancer research so that we can fund the studies that will make the most improvements in patient health," said Darby Anderson, a Jill's Legacy board member. "As the only young person's board attending the conference, we are very excited about this wonderful opportunity to learn and also to collaborate with some of the best lung cancer minds in the world. We are very thankful to the IASLC for this grant and cannot wait for the start of the conference."

Kim Norris, president of the Lung Cancer Foundation of America, said she was delighted to be able to represent the organization as one of the IASLC travel award recipients.

"LCFA is proud to continue its productive collaboration with the International Association for the Study of Lung Cancer," said Norris, a lung cancer widow who established LCFA together with two lung cancer survivors. "LCFA is grateful for the opportunity to work together with IASLC via this grant, which will allow us to expand our partnership internationally, thereby impacting lung cancer research funding opportunities worldwide."

Linda Wenger, executive director of Uniting Against Lung Cancer, said, "Uniting Against Lung Cancer is proud to have been selected as a travel award winner for the World Conference on Lung Cancer 2011 in Amsterdam, which brings together leaders in lung cancer research and treatment from around the world. As a leading funder for lung cancer research in the United States we are grateful for the opportunity to see the latest scientific advances and connect with key stakeholders worldwide to further our mission of funding critical lung cancer research that will lead to a cure."

This is the first year that the IASLC has offered travel awards to its biannual world conference, a leading forum for lung cancer specialists since 1978. IASLC is committed to engaging advocacy organizations in its mission to use all available means to eliminate lung cancer as a health threat for the individual patient and throughout the world.

"We are so pleased to announce our support of these advocacy organizations, and all advocates working to bring attention and funding to support lung cancer research and treatment," IASLC Director of Membership Kristin Richeimer said. "We know that these award winners will find the World Conference on Lung Cancer to be beneficial for their organizations' future work and their contributions to lung cancer advocacy, just as IASLC will receive equal benefit from this partnership."

All lung cancer advocates are encouraged to attend the 14th Annual World Conference on Lung Cancer. Advocate-specific content will include experts from around the world, and will features topics to help educate advocates about recent scientific and other developments that can help to increase expertise, raise awareness and improve patient access to treatment and positive outcomes.


'/>"/>

Contact: Rene McGaw
renee.mcgaw@ucdenver.edu
303-724-5796
International Association for the Study of Lung Cancer
Source:Eurekalert

Related medicine news :

1. IASLC to help advocacy organizations attend 14th World Conference on Lung Cancer in Amsterdam
2. NAMI Medical Director Honored with APA Patient Advocacy Award; Appears in CNN Health and Huffington Post Columns
3. Chicago Trial Attorney Inducted as Loyola University Chicago School of Law's First Cooney & Conway Chair in Advocacy
4. PMSI Advocacy Efforts Prompt CMS to Improve MSA Review Methodology
5. Veteran Advocacy Group to Announce New Program to Reform the VA
6. ASTRO awards 17 Advocacy Day travel grants
7. The Elizabeth Birt Center for Autism Law and Advocacy (EBCALA) Objects to Media Reports Tainting Autism Doctors and Misrepresenting Autism Treatments
8. Illinois State Senator Cullerton Recognized for Advocacy Work on Mental Health Issues
9. Father Channels His Grief into Advocacy, Promotes Simple Actions to Make Hospitals Safer for Children
10. Gladstones Robert Mahley to receive Research!America advocacy award
11. Nonprofit health organizations increase health literacy through social media
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... 20, 2017 , ... Announced that Clear Global ... services market) has entered into an agreement on September 1, 2017 with The ... is the first private Dental School to launch an online, accredited Post Graduate ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... gather for the National Athletic Trainers’ Association Annual Clinical Symposium and Expo. New ... It is also when Athletic Trainers are acknowledged by their peers with accolades ...
(Date:9/20/2017)... ... 2017 , ... Five consumer packaged goods (CPG) products were selected by the ... Nopavera Plus was named to the short list in the Specialty Supplements ... during presentations at SupplySide Central on Sept. 27 and 28 at Mandalay Bay Resort ...
(Date:9/20/2017)... Eugene, OR (PRWEB) , ... September 20, 2017 , ... ... OSHA 10- and 30-Hour and HAZWOPER 8-, 24- and 40-Hour courses from now until ... , In addition to offering these discounted prices to all businesses and government ...
(Date:9/20/2017)... ... ... “RECYCLED Ezekiel's Plan for Freedom from ADDICTION”: A Bible-inspired ... the creation of published author, Bill Miller. Bill Miller has a unique ... than a decade of addiction to prescription drugs. He has a Bachelor ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... N.Y. , Sept. 6, 2017   PDI , ... announced it will host an educational session focused on ... bloodstream infection (CLABSI) prevention at the 2017 Annual Scientific ... which will take place at the Phoenix ... from Sept. 16-19, will also feature PDI,s ...
(Date:9/5/2017)... N.J. , Sept. 5, 2017  Getinge, ... has created a vibrant charitable donation program -- ... and support congenital heart defect research by The ... providers and the general public are encouraged to ... and submit the completed artwork to the gallery ...
(Date:9/1/2017)... 1, 2017  Bayer will present the latest research from ... Medical Oncology (ESMO) 2017 Congress, September 8-12 in ... preclinical and clinical data on Bayer,s marketed portfolio and late-stage ... "We value the ... cancer research at ESMO," said Carsten Brunn , Head ...
Breaking Medicine Technology: